Amy E. Weaver - Jun 16, 2023 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
President and CFO
Signature
/s/ Sarah Dale, Attorney-in-Fact for Amy Weaver
Stock symbol
CRM
Transactions as of
Jun 16, 2023
Transactions value $
-$1,962,352
Form type
4
Date filed
6/20/2023, 05:00 PM
Previous filing
Apr 24, 2023
Next filing
Jun 23, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $650K +5.51K +15.01% $118.04 42.2K Jun 16, 2023 Direct F1
transaction CRM Common Stock Options Exercise $772K +4.78K +11.34% $161.50 47K Jun 16, 2023 Direct F1
transaction CRM Common Stock Options Exercise $1.77M +11.5K +24.47% $154.14 58.5K Jun 16, 2023 Direct F1
transaction CRM Common Stock Sale -$1.36M -6.43K -11% $211.25 52K Jun 16, 2023 Direct F1, F2
transaction CRM Common Stock Sale -$1.45M -6.84K -13.14% $212.12 45.2K Jun 16, 2023 Direct F1, F3
transaction CRM Common Stock Sale -$1.82M -8.51K -18.84% $213.46 36.7K Jun 16, 2023 Direct F1, F4
transaction CRM Common Stock Sale -$210K -996 -2.72% $211.26 35.7K Jun 16, 2023 Direct F1, F5
transaction CRM Common Stock Sale -$212K -1K -2.8% $212.14 34.7K Jun 16, 2023 Direct F1, F6
transaction CRM Common Stock Sale -$108K -504 -1.45% $213.50 34.2K Jun 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -5.51K -100% $0.00* 0 Jun 16, 2023 Common Stock 5.51K $118.04 Direct F1, F7
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -4.78K -12.5% $0.00 33.5K Jun 16, 2023 Common Stock 4.78K $161.50 Direct F1, F8
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -11.5K -10.17% $0.00 101K Jun 16, 2023 Common Stock 11.5K $154.14 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023.
F2 Weighted average price. These shares were sold in multiple transactions at prices ranging from $210.6500 to $211.6450 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $211.6600 to $212.6500 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $212.6600 to $213.5000 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Weighted average price. These shares were sold in multiple transactions at prices ranging from $210.6500 to $211.6400 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 Weighted average price. These shares were sold in multiple transactions at prices ranging from $211.7000 to $212.6300 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 Option vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F8 Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F9 Option vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.